• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国 1993 年至 2009 年按年龄组和组织学类型划分的原位和浸润性宫颈癌发病率趋势。

Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.

机构信息

Cancer Registration and Statistics Branch, National Cancer Control Institute, National Cancer Center, Goyang, Korea.

出版信息

PLoS One. 2013 Aug 16;8(8):e72012. doi: 10.1371/journal.pone.0072012. eCollection 2013.

DOI:10.1371/journal.pone.0072012
PMID:23977194
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3745377/
Abstract

OBJECTIVE

Our study aims to describe changes in carcinoma in situ (CIS) and invasive cervical carcinoma (ICC) in Korean women diagnosed between 1993 and 2009.

METHODS

All cases of CIS and invasive cervical carcinoma diagnosed from 1993 to 2009 in the Korean National Cancer Incidence database were analyzed. Age-standardized rates (ASRs) and annual percent changes (APCs) in incidence rates were compared according to age and histological type. Additionally, we used Korea National Health and Nutrition Examination Survey (KNHANES) to know the association between screening rate for cervical cancer and incidence rate of cervical cancer.

RESULTS

Between 1993 and 2009, 72,240 cases of ICC were reported in Korea. Total incidence rate of ICC was 14.7 per 100,000 females. ASRs of ICC declined 3.8% per year, from 19.3 per 100,000 in 1993 to 10.5 per 100,000 in 2009. Although the overall incidence rate of adenocarcinoma remained stable, invasive squamous cell carcinoma showed a decreasing trend (APC -4.2%). For women aged 60-79 years, ASRs for squamous cell carcinoma increased from 1993 to 2001, and decreased from 2001 to 2009 (APC: -4.6%). Total 62,300 cases of CIS were diagnosed from 1993 to 2009. Total incidence rate of CIS was 12.2 per 100,000 females. ASRs of CIS increased 5.7% per year, from 7.5 per 100,000 in 1993 to 19.0 per 100,000 in 2009. Adenocarcinoma in situ increased 13.2% per year. There was a strong positive correlation between screening rate for cervical cancer and incidence rate for CIS (p-value = 0.03) whereas screening rate showed a strong negative correlation with incidence rate for squamous ICC (p-value = 0.04).

CONCLUSIONS

The increasing trend in CIS, coupled with a decreasing trend in ICC, suggests the important role of cervix cancer screening. The incidence of adenocarcinoma showed a plateau, but the incidence of adenocarcinoma in situ showed an increasing trend.

摘要

目的

本研究旨在描述 1993 年至 2009 年间在韩国被诊断为原位癌(CIS)和浸润性宫颈癌(ICC)的女性患者的变化情况。

方法

对韩国国家癌症发病率数据库中 1993 年至 2009 年间诊断的所有 CIS 和浸润性宫颈癌病例进行分析。根据年龄和组织学类型比较发病率的年龄标准化率(ASR)和年度百分比变化(APC)。此外,我们还利用韩国国家健康与营养调查(KNHANES)了解宫颈癌筛查率与宫颈癌发病率之间的关系。

结果

1993 年至 2009 年间,韩国共报告 72240 例 ICC。ICC 的总发病率为每 10 万名女性 14.7 例。ICC 的 ASR 每年下降 3.8%,从 1993 年的每 10 万人 19.3 例降至 2009 年的每 10 万人 10.5 例。尽管腺癌的总体发病率保持稳定,但浸润性鳞状细胞癌呈下降趋势(APC-4.2%)。对于 60-79 岁的女性,鳞状细胞癌的 ASR 从 1993 年至 2001 年增加,然后从 2001 年至 2009 年下降(APC:-4.6%)。1993 年至 2009 年间共诊断出 62300 例 CIS。CIS 的总发病率为每 10 万名女性 12.2 例。CIS 的 ASR 每年增加 5.7%,从 1993 年的每 10 万人 7.5 例增加到 2009 年的每 10 万人 19.0 例。原位腺癌每年增加 13.2%。宫颈癌筛查率与 CIS 发病率之间存在强正相关(p 值=0.03),而筛查率与鳞状 ICC 发病率之间存在强负相关(p 值=0.04)。

结论

CIS 的上升趋势,加上 ICC 的下降趋势,表明宫颈癌筛查发挥了重要作用。腺癌的发病率呈平台期,但原位腺癌的发病率呈上升趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220a/3745377/0d6e4c475b0d/pone.0072012.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220a/3745377/daf44ee53894/pone.0072012.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220a/3745377/19b2a279b6f2/pone.0072012.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220a/3745377/0d6e4c475b0d/pone.0072012.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220a/3745377/daf44ee53894/pone.0072012.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220a/3745377/19b2a279b6f2/pone.0072012.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/220a/3745377/0d6e4c475b0d/pone.0072012.g003.jpg

相似文献

1
Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.韩国 1993 年至 2009 年按年龄组和组织学类型划分的原位和浸润性宫颈癌发病率趋势。
PLoS One. 2013 Aug 16;8(8):e72012. doi: 10.1371/journal.pone.0072012. eCollection 2013.
2
Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985-2003.1985 - 2003年密歇根州原位和浸润性宫颈癌的总负担及发病率
Cancer. 2008 Nov 15;113(10 Suppl):2946-54. doi: 10.1002/cncr.23747.
3
Incidence trends in invasive uterine cervix cancer and carcinoma in situ in Incheon, South Korea.韩国仁川浸润性宫颈癌和原位癌的发病率趋势。
Asian Pac J Cancer Prev. 2011;12(8):1985-8.
4
[In situ and invasive cervical cancer epidemiology in the province of Girona, Spain 1990-2004: incidence, mortality, survival and screening history].[1990 - 2004年西班牙赫罗纳省原位和浸润性宫颈癌流行病学:发病率、死亡率、生存率及筛查史]
Med Clin (Barc). 2011 Feb 26;136(5):192-8. doi: 10.1016/j.medcli.2010.07.010. Epub 2010 Nov 3.
5
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry.1999-2018 年韩国国家癌症登记处宫颈癌的发病率和治疗结果。
J Gynecol Oncol. 2023 Mar;34(2):e39. doi: 10.3802/jgo.2023.34.e39. Epub 2023 Jan 19.
6
Cervical cancer incidence in Denmark over six decades (1943-2002).丹麦六十年来(1943 - 2002年)的宫颈癌发病率。
Acta Obstet Gynecol Scand. 2006;85(1):106-11. doi: 10.1080/00016340500324423.
7
A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.一项关于鳞状细胞癌和腺癌筛查的瑞典纵向研究:有效性和过度治疗的证据。
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2641-8. doi: 10.1158/1055-9965.EPI-07-0278.
8
Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013.2004年至2013年期间,荷兰浸润性和原位宫颈腺癌的发病率呈上升趋势。
Cancer Med. 2017 Feb;6(2):416-423. doi: 10.1002/cam4.971. Epub 2017 Jan 19.
9
Cervical cancer incidence and survival in Korea: 1993-2002.韩国1993 - 2002年宫颈癌的发病率及生存率
Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1833-8. doi: 10.1111/j.1525-1438.2006.00708.x.
10
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among Tunisian women.突尼斯女性宫颈癌和鳞状细胞癌的发病率趋势
Asian Pac J Cancer Prev. 2010;11(3):777-80.

引用本文的文献

1
Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry.1999 - 2019年韩国妇科癌症(包括宫颈癌、子宫癌、卵巢癌、阴道癌、外阴癌和妊娠滋养细胞肿瘤)的发病率和生存率:韩国中央癌症登记处
Obstet Gynecol Sci. 2023 Nov;66(6):545-561. doi: 10.5468/ogs.23208. Epub 2023 Oct 27.
2
Molecular correlates of invasion pattern in HPV-associated endocervical adenocarcinoma: emergence of two distinct risk-stratified tiers.HPV 相关宫颈内膜腺癌侵袭模式的分子相关性:两个明显的风险分层级别的出现。
Histopathology. 2023 Jun;82(7):1067-1078. doi: 10.1111/his.14893. Epub 2023 Mar 20.
3

本文引用的文献

1
Changing demographics of cervical cancer in the United States (1973-2008).美国宫颈癌发病人口统计学特征的变迁(1973-2008 年)。
Gynecol Oncol. 2012 Sep;126(3):330-3. doi: 10.1016/j.ygyno.2012.05.035. Epub 2012 Jun 2.
2
Performance of papanicolaou testing and detection of cervical carcinoma in situ in participants of organized cervical cancer screening in South Korea.韩国组织宫颈癌筛查参与者巴氏涂片检测和宫颈原位癌检测的性能。
PLoS One. 2012;7(4):e35469. doi: 10.1371/journal.pone.0035469. Epub 2012 Apr 16.
3
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009.
Association of Late Marriage and Low Childbirth with Cervical Cancer Screening among Korean Women: Results from a Nationwide Survey.
韩国女性晚婚和低生育率与宫颈癌筛查的关联:一项全国性调查结果
Cancers (Basel). 2022 Jan 10;14(2):327. doi: 10.3390/cancers14020327.
4
Barriers and strategies for cervical cancer screening: What do female university students know and want?宫颈癌筛查的障碍和策略:女大学生知多少,想要什么?
PLoS One. 2021 Oct 5;16(10):e0257529. doi: 10.1371/journal.pone.0257529. eCollection 2021.
5
Clinicopathological and prognostic significance of immunophenotypic characterization of endocervical adenocarcinoma using CLDN18, CDH17, and PAX8 in association with HPV status.采用 CLDN18、CDH17 和 PAX8 联合 HPV 状态对宫颈腺癌进行免疫表型特征分析的临床病理和预后意义。
Virchows Arch. 2022 Feb;480(2):269-280. doi: 10.1007/s00428-021-03207-1. Epub 2021 Sep 28.
6
The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry.1999 - 2017年韩国宫颈癌、卵巢癌和子宫内膜癌的发病率及生存率:韩国中央癌症登记处
Obstet Gynecol Sci. 2021 Sep;64(5):444-453. doi: 10.5468/ogs.21116. Epub 2021 Aug 17.
7
Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program.巴氏涂片筛查对诊断时宫颈癌分期的影响:来自韩国国家癌症筛查计划的结果。
J Gynecol Oncol. 2021 Sep;32(5):e81. doi: 10.3802/jgo.2021.32.e81.
8
Trend analysis of process quality indicators for the Korean National Cervical Cancer Screening Program from 2005 to 2013.2005 年至 2013 年韩国国家宫颈癌筛查计划过程质量指标的趋势分析。
J Gynecol Oncol. 2021 Jan;32(1):e14. doi: 10.3802/jgo.2021.32.e14. Epub 2020 Dec 7.
9
circEYA1 Functions as a Sponge of miR-582-3p to Suppress Cervical Adenocarcinoma Tumorigenesis via Upregulating CXCL14.环状EYA1作为miR-582-3p的海绵,通过上调CXCL14抑制宫颈腺癌的肿瘤发生。
Mol Ther Nucleic Acids. 2020 Oct 22;22:1176-1190. doi: 10.1016/j.omtn.2020.10.026. eCollection 2020 Dec 4.
10
The Burden of Cervical Cancer in Korea: A Population-Based Study.韩国的宫颈癌负担:一项基于人群的研究。
Int J Environ Res Public Health. 2020 Aug 30;17(17):6308. doi: 10.3390/ijerph17176308.
韩国癌症统计数据:2009 年的发病率、死亡率、生存率和患病率。
Cancer Res Treat. 2012 Mar;44(1):11-24. doi: 10.4143/crt.2012.44.1.11. Epub 2012 Mar 31.
4
Current status of the National Cancer Screening Program for cervical cancer in Korea, 2009.韩国 2009 年国家宫颈癌筛查计划的现状。
J Gynecol Oncol. 2012 Jan;23(1):16-21. doi: 10.3802/jgo.2012.23.1.16. Epub 2012 Jan 9.
5
Overview of the National Cancer screening programme and the cancer screening status in Korea.韩国国家癌症筛查计划及癌症筛查现状概述。
Asian Pac J Cancer Prev. 2011;12(3):725-30.
6
Worldwide burden of cervical cancer in 2008.2008 年全球宫颈癌负担。
Ann Oncol. 2011 Dec;22(12):2675-2686. doi: 10.1093/annonc/mdr015. Epub 2011 Apr 6.
7
Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.5 大洲人类乳头瘤病毒(HPV)在宫颈的流行率:100 万例细胞学正常女性的荟萃分析。
J Infect Dis. 2010 Dec 15;202(12):1789-99. doi: 10.1086/657321. Epub 2010 Nov 10.
8
Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania.波罗的海国家、保加利亚和罗马尼亚的宫颈癌发病率和死亡率趋势。
Int J Cancer. 2011 Apr 15;128(8):1899-907. doi: 10.1002/ijc.25525.
9
Factors associated with use of breast cancer screening services by women aged >or= 40 years in Korea: the third Korea National Health and Nutrition Examination Survey 2005 (KNHANES III).韩国 40 岁及以上女性使用乳腺癌筛查服务的相关因素:第三次韩国国家健康和营养调查 2005 年(KNHANES III)。
BMC Cancer. 2010 Apr 16;10:144. doi: 10.1186/1471-2407-10-144.
10
Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences.台湾国家子宫颈癌筛检计划的成效:12年经验
Br J Cancer. 2009 Jul 7;101(1):174-7. doi: 10.1038/sj.bjc.6605139. Epub 2009 Jun 16.